BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Palmer JM, Kirby JA, Jones DE. The immunology of primary biliary cirrhosis: the end of the beginning. Clin Exp Immunol. 2002;129:191-197. [PMID: 12165073 DOI: 10.1046/j.1365-2249.2002.01948.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Mori T, Ohira H, Kuroda M, Kato M, Yamaguchi Y, Kochi H. Characterization of Autoantibodies against the E1α Subunit of Branched-Chain 2-Oxoacid Dehydrogenase in Patients with Primary Biliary Cirrhosis. Int J Hepatol 2012;2012:369740. [PMID: 22778969 DOI: 10.1155/2012/369740] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Lazaridis KN, Strazzabosco M, Larusso NF. The cholangiopathies: Disorders of biliary epithelia. Gastroenterology 2004;127:1565-77. [DOI: 10.1053/j.gastro.2004.08.006] [Cited by in Crossref: 253] [Cited by in F6Publishing: 241] [Article Influence: 14.1] [Reference Citation Analysis]
3 Selmi C, Ross SR, Ansari AA, Invernizzi P, Podda M, Coppel RL, Gershwin M. Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology 2004;127:493-501. [DOI: 10.1053/j.gastro.2004.05.033] [Cited by in Crossref: 85] [Cited by in F6Publishing: 70] [Article Influence: 4.7] [Reference Citation Analysis]
4 Macdonald P, Palmer J, Kirby JA, Jones DE. Apoptosis as a mechanism for cell surface expression of the autoantigen pyruvate dehydrogenase complex. Clin Exp Immunol 2004;136:559-67. [PMID: 15147361 DOI: 10.1111/j.1365-2249.2004.02484.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
5 Bassendine MF. Molecular Basis of Primary Biliary Cirrhosis. Molecular Pathogenesis of Cholestasis. Boston: Springer US; 2004. pp. 221-46. [DOI: 10.1007/978-1-4419-9034-1_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Jones DE. Pathogenesis of primary biliary cirrhosis. Clin Liver Dis. 2008;12:305-321; viii. [PMID: 18456182 DOI: 10.1016/j.cld.2008.02.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
7 Kouroumalis E, Notas G. Pathogenesis of primary biliary cirrhosis: A unifying model. World J Gastroenterol 2006; 12(15): 2320-2327 [PMID: 16688819 DOI: 10.3748/wjg.v12.i15.2320] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
8 Fehér E, Pongor É, Altdorfer K, Kóbori L, Lengyel G. Neuroimmunomodulation in human autoimmune liver disease. Cell Tissue Res 2013;354:543-50. [PMID: 23881405 DOI: 10.1007/s00441-013-1683-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
9 Trauner M, Boyer JL. Cholestatic syndromes: . Current Opinion in Gastroenterology 2003;19:216-31. [DOI: 10.1097/00001574-200305000-00005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
10 Yin Q, Li J, Xia Y, Zhang R, Wang J, Lu W, Zhou Y, Zheng Y, Abudumijiti H, Chen R, Chen K, Li S, Liu T, Wang F, Lu J, Zhou Y, Guo C. Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis. Drug Des Devel Ther 2015;9:5407-19. [PMID: 26491252 DOI: 10.2147/DDDT.S92041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
11 Stevens AM, Michael Mcdonnell W, Mullarkey ME, Pang JM, Leisenring W, Lee Nelson J. Liver biopsies from human females contain male hepatocytes in the absence of transplantation. Lab Invest 2004;84:1603-9. [DOI: 10.1038/labinvest.3700193] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 3.2] [Reference Citation Analysis]
12 Fritzler MJ, Manns MP. Anti-mitochondrial autoantibodies. Clinical and Applied Immunology Reviews 2002;3:87-113. [DOI: 10.1016/s1529-1049(02)00058-2] [Cited by in Crossref: 18] [Article Influence: 0.9] [Reference Citation Analysis]
13 Weetman AP. Non-thyroid autoantibodies in autoimmune thyroid disease. Best Pract Res Clin Endocrinol Metab. 2005;19:17-32. [PMID: 15826920 DOI: 10.1016/j.beem.2004.11.004] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
14 Robe AJ, Kirby JA, Jones DE, Palmer JM. A key role for autoreactive B cells in the breakdown of T-cell tolerance to pyruvate dehydrogenase complex in the mouse. Hepatology 2005;41:1106-12. [PMID: 15830397 DOI: 10.1002/hep.20642] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
15 Berg CP, Stein GM, Klein R, Pascu M, Berg T, Kammer W, Priemer M, Nordheim A, Schulze-osthoff K, Gregor M, Wesselborg S, Berg PA. Demonstration of PDC-E1 subunits as major antigens in the complement-fixing fraction M4 and re-evaluation of PDC-E1-specific antibodies in PBC patients. Liver Int 2006;26:846-55. [DOI: 10.1111/j.1478-3231.2006.01303.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
16 Oikawa T, Takahashi H, Ishikawa T, Hokari A, Otsuki N, Azuma M, Zeniya M, Tajiri H. Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease. Pathol Int. 2007;57:485-492. [PMID: 17610472 DOI: 10.1111/j.1440-1827.2007.02129.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
17 Nguyen DL, Juran BD, Lazaridis KN. Primary biliary cirrhosis. Best Pract Res Clin Gastroenterol. 2010;24:647-654. [PMID: 20955967 DOI: 10.1016/j.bpg.2010.07.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
18 Lazaridis KN, Juran BD, Boe GM, Slusser JP, de Andrade M, Homburger HA, Ghosh K, Dickson ER, Lindor KD, Petersen GM. Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis. Hepatology 2007;46:785-92. [PMID: 17680647 DOI: 10.1002/hep.21749] [Cited by in Crossref: 102] [Cited by in F6Publishing: 83] [Article Influence: 6.8] [Reference Citation Analysis]
19 Chuang YH, Lian ZX, Cheng CM, Lan RY, Yang GX, Moritoki Y, Chiang BL, Ansari AA, Tsuneyama K, Coppel RL, Gershwin ME. Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives. J Autoimmun. 2005;25:126-132. [PMID: 16243485 DOI: 10.1016/j.jaut.2005.08.009] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 4.2] [Reference Citation Analysis]
20 Vierling JM. Primary biliary cirrhosis and autoimmune cholangiopathy. Clin Liver Dis. 2004;8:177-194. [PMID: 15062200 DOI: 10.1016/s1089-3261(03)00132-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Sun Y, Haapanen K, Li B, Zhang W, Van de Water J, Gershwin ME. Women and primary biliary cirrhosis. Clin Rev Allergy Immunol 2015;48:285-300. [PMID: 25241227 DOI: 10.1007/s12016-014-8449-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
22 Charatcharoenwitthaya P, Lindor KD. Current concepts in the pathogenesis of primary biliary cirrhosis. Annals of Hepatology 2005;4:161-75. [DOI: 10.1016/s1665-2681(19)32061-7] [Cited by in Crossref: 12] [Article Influence: 0.7] [Reference Citation Analysis]